Glenn Vergauwen
Overview
Explore the profile of Glenn Vergauwen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
1128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goker M, Deblaere S, Denys H, Vergauwen G, Naert E, Veldeman L, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296857
Background: The prognostic and predictive role of stromal tumor-infiltrating lymphocytes (sTILs) is undetermined in pleomorphic invasive lobular cancer (pILC). The same applies for the expression of PD-1/PD-L1 in this rare...
2.
Van Dorpe S, Lippens L, Boiy R, Pinheiro C, Vergauwen G, Rappu P, et al.
J Nanobiotechnology
. 2023 May;
21(1):157.
PMID: 37208684
Background: Extracellular vesicles (EV) are extensively studied in human body fluids as potential biomarkers for numerous diseases. Major impediments of EV-based biomarker discovery include the specificity and reproducibility of EV...
3.
Dhondt B, Pinheiro C, Geeurickx E, Tulkens J, Vergauwen G, van der Pol E, et al.
J Extracell Vesicles
. 2023 May;
12(5):e12315.
PMID: 37202906
The analysis of extracellular vesicles (EV) in blood samples is under intense investigation and holds the potential to deliver clinically meaningful biomarkers for health and disease. Technical variation must be...
4.
Vergauwen G, Cools P, Denys H, Fiers T, Van de Vijver K, Veldeman L, et al.
BMJ Open
. 2023 Apr;
13(4):e068053.
PMID: 37041060
Introduction: Breast cancer is the most common cancer type in women worldwide. Due to hormone receptor positivity in the majority of the breast cancer tumours is endocrine therapy a crucial...
5.
Vakaet V, Van Hulle H, Van de Vijver K, Hilderson I, Naert E, De Neve W, et al.
Breast
. 2022 Jan;
62:10-15.
PMID: 35091184
Objective: Neo-adjuvant radiotherapy (NART) for breast cancer has shown promising survival results in retrospective trials. However, there are some obstacles such as a chemotherapy delay, an increased overall treatment time...
6.
Vergauwen G, Tulkens J, Pinheiro C, Avila Cobos F, Dedeyne S, De Scheerder M, et al.
J Extracell Vesicles
. 2021 Aug;
10(10):e12122.
PMID: 34429857
Separating extracellular vesicles (EV) from blood plasma is challenging and complicates their biological understanding and biomarker development. In this study, we fractionate blood plasma by combining size-exclusion chromatography (SEC) and...
7.
Dhondt B, Geeurickx E, Tulkens J, Van Deun J, Vergauwen G, Lippens L, et al.
J Extracell Vesicles
. 2020 Apr;
9(1):1736935.
PMID: 32284825
Extracellular vesicles (EV) are increasingly being recognized as important vehicles of intercellular communication and promising diagnostic and prognostic biomarkers in cancer. Despite this enormous clinical potential, the plethora of methods...
8.
Geeurickx E, Tulkens J, Dhondt B, Van Deun J, Lippens L, Vergauwen G, et al.
Nat Commun
. 2019 Jul;
10(1):3288.
PMID: 31337761
Recent years have seen an increase of extracellular vesicle (EV) research geared towards biological understanding, diagnostics and therapy. However, EV data interpretation remains challenging owing to complexity of biofluids and...
9.
Tulkens J, Vergauwen G, Van Deun J, Geeurickx E, Dhondt B, Lippens L, et al.
Gut
. 2018 Dec;
69(1):191-193.
PMID: 30518529
No abstract available.
10.
Vergauwen G, Dhondt B, Van Deun J, De Smedt E, Berx G, Timmerman E, et al.
Sci Rep
. 2017 Jun;
7(1):2704.
PMID: 28577337
Identification and validation of extracellular vesicle (EV)-associated biomarkers requires robust isolation and characterization protocols. We assessed the impact of some commonly implemented pre-analytical, analytical and post-analytical variables in EV research....